Pharmacokinetics of Substrate Uptake and Distribution in Murine Brain After Nasal Instillation

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pharmaceutical Research

• Publication date

  2005-02-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11095-004-1191-5PMID 15783071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal Administration

  2004cited by this paper
• Neuronal and Glial Expression of the Multidrug Resistance Gene Product in an Experimental Epilepsy Model

  2004cited by this paper
• Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

  2004cited by this paper
• Drug transport at the blood-brain barrier and the choroid plexus.

  2004cited by this paper
• P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation

  2003cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

  2003cited by this paper
• Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.

  2002cited by this paper
• Permeability issues in nasal drug delivery.

  2002cited by this paper
• Clinical Pharmacology of Opioids for Pain

  2002cited by this paper
• Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.

  2001cited by this paper
• CFTR, MDR1, and MRP1 Immunolocalization in Normal Human Nasal Respiratory Mucosa

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient Mice

  2000cited by this paper
• Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.

  1999cited by this paper
• Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat

  1998cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1998cited by this paper
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.

  1998cited by this paper
• Intranasal drug delivery.

  1998cited by this paper
• P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain.

  1997cited by this paper
• Multidrug resistance: molecular mechanisms and clinical relevance

  1997cited by this paper
• The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?

  1997influential reference
• Uptake of nickel into the brain via olfactory neurons in rats.

  1997cited by this paper
• Quantitative analysis of the olfactory pathway for drug delivery to the brain.

  1995cited by this paper
• Mouse hepatitis virus and herpes simplex virus move along different CNS pathways.

  1993cited by this paper
• The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug.

  1991cited by this paper
• P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins

  1989cited by this paper
• Nasal absorption of testosterone in rats.

  1984cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper

• Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles.

  2024cites this paper
• Whole body physiology model to simulate respiratory depression of fentanyl and associated naloxone reversal

  2024cites this paper
• Whole Body PBPK Model of Nasal Naloxone Administration to Measure Repeat Dosing Requirements During Fentanyl Overdose

  2023cites this paper
• Applications of Polymeric Nanoparticle in Nose to Brain Drug Delivery

  2023cites this paper
• Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs

  2023cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines

  2021cites this paper
• FGF20 Protected Against BBB Disruption After Traumatic Brain Injury by Upregulating Junction Protein Expression and Inhibiting the Inflammatory Response

  2021cites this paper
• Nanotechnologies for intranasal drug delivery: an update of literature

  2021cites this paper
• Nose to brain drug delivery of nanoformulations in the treatment of migraine

  2021cites this paper
• Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease

  2020cites this paper
• Intranasal administration of progesterone: A potential efficient route of delivery for cerebroprotection after acute brain injuries

  2019cites this paper
• Nanoparticle systems for nose-to-brain delivery

  2019cites this paper
• Strategies to facilitate or block nose-to-brain drug delivery.

  2019cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• Medicinski proizvodi namijenjeni nazalnoj primjeni lijekova

  2016cites this paper
• A review of intranasal formulations for the treatment of seizure emergencies.

  2016cites this paper
• Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans

  2015cites this paper
• NASAL DRUG DELIVERY SYSTEM: AN EMERGING APPROACH FOR BRAIN TARGETING

  2014cites this paper
• NASAL DOSAGE FORMS AND DEVICES FOR INTRANASAL DRUG DELIVERY

  2014cites this paper
• Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation

  2014cites this paper
• An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

  2012cites this paper
• Intranasal Treatment of Central Nervous System Dysfunction in Humans

  2012cites this paper
• Asymmetry in parkinsonism, spreading pathogens and the nose.

  2012cites this paper
• Non-invasive Systemic Drug Delivery via Nasal Route: A Review

  2011cites this paper
• Chronic Intranasal Treatment with an Anti-Aβ30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

  2011cites this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cites this paper
• Intranasal insulin: from nose to brain.

  2010cites this paper
• Intranasal Delivery—Modification of Drug Metabolism and Brain Disposition

  2010cites this paper
• Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation.

  2010cites this paper
• Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.

  2009cites this paper
• Intranasal drug delivery: how, why and what for?

  2009cites this paper
• Experimental approaches to measuring brain exposure: Rate, extent and regional distribution

  2007cites this paper
• Evaluating transport of manganese from olfactory mucosa to striatum by pharmacokinetic modeling.

  2007influential citation
• Intranasal delivery: physicochemical and therapeutic aspects.

  2007cites this paper
• A computer-based approach to assess the perception of composite odour intensity: a step towards automated olfactometry calibration

  2006cites this paper
• Functional Evidence for P-glycoprotein at the Nose-Brain Barrier

  2004cites this paper